These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4921094)

  • 1. The protective effect in bank voles of some strains of BCG.
    Ladefoged A; Bunch-Christensen K; Guld J
    Bull World Health Organ; 1970; 43(1):71-90. PubMed ID: 4921094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCG.
    Portelance V; Brasseur R; Boulanger RP
    Can J Microbiol; 1975 Oct; 21(10):1492-9. PubMed ID: 1104114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency and suppurative adenitis in BCG vaccination.
    Gheorghiu M; Carnus H; Lagrange P; Chambon L
    Dev Biol Stand; 1978; 41():79-84. PubMed ID: 381076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virulence of some strains of BCG for golden hamsters.
    Bunch-Christensen K; Ladefoged A; Guld J
    Bull World Health Organ; 1968; 39(5):821-8. PubMed ID: 4893582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic S
    Infect Immun; 2005 Aug; 73(8):4676-83. PubMed ID: 16040980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice after airborne infection with various strains of BCG.
    Lefford MJ
    Am Rev Respir Dis; 1978 Jan; 117(1):103-9. PubMed ID: 339795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis.
    Palmer MV; Thacker TC; Waters WR
    Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D; Anagnoste V; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):91-101. PubMed ID: 4936247
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Mar; 24(10):1593-600. PubMed ID: 16257099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.